Analyst Ratings for Health Catalyst Inc. (HCAT)
HCAT Rating Summary
HCAT Price Target Summary
- Highest: $42.00 (Goldman Sachs)
- Lowest: $19.00 (RBC Capital)
- Average: $31.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$31.10 (+114.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/14/2022 | Guggenheim | Jack Wallace | New Coverage | Buy (N/A) |
39.00 (N/A) |
24.27 (14.49) |
-40.3% | Details |
| 3/17/2022 | Jefferies | Glen Santangelo | Upgrade | Buy (Hold) |
28.00 (31.00) |
22.56 (14.49) |
-35.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
